As a result, the data presented above show that fetuin-A may be employed as a unique biological marker for the diagnosis of several metabolic illnesses including dyslipidemia, poor glycemic control, which all share responsibility for mitochondrial dysfunction, which increases reactive oxygen species (ROS) and eventually leads to MASLD [45]. This evidence concerns the gene AHSG and metabolic dysfunction-associated steatotic liver disease.